Enhanced green fluorescent protein expression may be used to monitor murine coronavirus spread in vitro and in the mouse central nervous system

References

• Bond CW, Leibowitz JL, Robb JA (1979). Pathogenic murine coronaviruses. II. Characterization of virus-specific pro-teins of murine coronaviruses JHMV and A59V. Virology 94: 371–384.
   Google Scholar
• Cormack BP, Valdivia RH, Falkow S (1996). FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173: 33–38.
   PubMed Web of Science ®Google Scholar
• Das Sarma J, Fu L, Tsai JC, Weiss SR, Lavi E (2000). Demyeli-nation determinants map to the spike glycoprotein gene of coronavirus mouse hepatitis virus. I Virol 74: 9206–9213.
   PubMed Web of Science ®Google Scholar
• Fischer F, Stegen CF, Koetzner CA, Masters PS (1997). Anal-ysis of a recombinant mouse hepatitis virus expressing a foreign gene reveals a novel aspect of coronavirus tran-scription. I Virol 71: 5148–5160.
   Google Scholar
• Gombold JL, Hingley ST, Weiss SR (1993). Fusion-defective mutants of mouse hepatitis virus A59 contain a mutation in the spike protein cleavage signal. I Virol 67: 4504–4512.
   Google Scholar
• Gombold JL, Weiss SR (1992). Mouse hepatitis virus A59 increases steady state levels of MHC mRNAs in primary glial cell cultures and in the murine central nervous system. Microb Pathogen 13: 493–505.
   Google Scholar
• Haas J, Park EC, Seed B (1996). Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr Biol 6: 315–324.
   PubMed Web of Science ®Google Scholar
• Houtman JJ, Fleming JO (1996). Dissociation of demyeli-nation and viral clearance in congenitally immunod-eficient mice infected with murine coronavirus JHM. J NeuroVirol 2: 101–110.
   Web of Science ®Google Scholar
• Kuo L, Godeke GJ, Raamsman MJ, Masters PS, Rottier PJ (2000). Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: Crossing the host cell species barrier. I Virol 74: 1393–1406.
   PubMed Web of Science ®Google Scholar
• Lavi E, Gilden DH, Wroblewska Z, Rorke LB, Weiss SR (1984). Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology 34: 597–603.
   PubMedGoogle Scholar
• Lavi E, Murray EM, Makino S, Stohlman SA, Lai MMC, Weiss SR (1990). Determinants of coronavirus MHV pathogenesis are localized to 3' portions of the genome as determined by ribonucleic acid-ribonucleic acid re-combination. Lab Invest 62: 570–578.
   Google Scholar
• Leparc-Goffart I, Hingley ST, Chua MM, Jiang X, Lavi E, Weiss SR (1997). Altered pathogenesis of a mutant of the murine coronavirus MHV-A59 is associated with a Q159L amino acid substitution in the spike protein. Virology 239: 1–10.
   Google Scholar
• Leparc-Goffart I, Hingley ST, Chua MM, Phillips J, Lavi E, Weiss SR (1998). Targeted recombination within the spike gene of murine coronavirus mouse hepatitis virus-A59: Q159 is a determinant of hepatotropism. I Virol 72: 9628–9636.
   PubMed Web of Science ®Google Scholar
• Luytjes W, Bredenbeek PJ, Noten AF, Horzinek MC, Spaan, WJM (1988). Sequence of mouse hepatitis virus A59 mRNA 2: indications for RNA recombination between coronaviruses and influenza C virus. Virology 166: 415–422.
   Google Scholar
• Matthews AE, Weiss SR, Shlomchik MJ, Hannum LG, Gombold JL, Paterson Y (2001). Antibody is required for clearance of infectious murine hepatitis virus A59 from the central nervous system, but not the liver. Jimmunol 167: 5254–5263.
   Google Scholar
• Navas S, Seo SH, Chua MM, Sarma JD, Lavi E, Hingley ST, Weiss SR (2001). Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis. I Virol 75: 2452–2457.
   Google Scholar
• Ontiveros E, Kuo L, Masters PS, Perlman S (2001). Inacti-vation of expression of gene 4 of mouse hepatitis virus strain JHM does not affect virulence in the murine CNS. Virology 289: 230–238.
   Google Scholar
• Phillips JJ, Chua MM, Lavi E, Weiss SR (1999). Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: The murine coronavirus spike protein is a major determinant of neurovirulence. I Virol 73: 7752–7760.
   PubMed Web of Science ®Google Scholar
• Phillips JJ, Chua M, Seo SH, Weiss SR (2001). Multiple re-gions of the murine coronavirus spike glycoprotein in-fluence neurovirulence. I NeuroVirol 7: 421–431.
   PubMed Web of Science ®Google Scholar
• Sanger F, Nicklen S, Coulson AP (1977). DNA sequencing with chain-terminating inhibitors. Proc Nat] Acad Sci USA 74: 5463–5467.
   PubMedGoogle Scholar
• Schwarz B, Routledge E, Siddell SG (1990). Murine coron-avirus nonstructural protein ns2 is not essential for virus replication in transformed cells. I Virol 64: 4784–4791.
   Google Scholar
• Slifka MK, Pagarigan R, Mena I, Feuer R, Whitton JL (2001). Using recombinant coxsackievirus B3 to evaluate the in-duction and protective efficacy of CD8+ T cells during picornavirus infection. I Virol 75: 2377–2387.
   PubMed Web of Science ®Google Scholar
• Smith BN, Banfield BW, Smeraski CA, Wilcox CL, Dudek FE, Enquist LW, Pickard GE (2000). Pseudorabies virus expressing enhanced green fluorescent protein: a tool for in vitro electrophysiological analysis of transsynap-tically labeled neurons in identified central nervous sys-tem circuits. Proc Nat] Acad Sci USA 97: 9264–9269.
   Google Scholar
• Sutherland RM, Chua MM, Lavi E, Weiss SR, Paterson Y (1997). CD4+ and CD8+ T cells are not major effectors of mouse hepatitis virus A59-induced demyelinating dis-ease. J NeuroVirol 3: 225–228.
   Web of Science ®Google Scholar
• Yokomori K, Lai MMC (1991). Mouse hepatitis virus S se-quence reveals that nonstructural proteins ns4 and ns5a are not essential for murine coronavirus replication. I Virol 65: 5605–5608.
   Google Scholar